Qrons Inc.: Qrons Announces Filing Of Provisional Patent Application In Furtherance Of Its QS200 Product Candidate
NEW YORK, NY / ACCESSWIRE / April 12, 2022 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company dedicated to developing next generation treatments for unmet neuronal diseases, using tissue engineering
New York United States Ido Merfeld Kostenloser Wertpapierhandel Jonah Meer Polypseudorotaxane Hydrogels
Source: finanznachrichten.de